Mortality Implications of Primary Percutaneous Coronary Intervention Treatment Delays: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction Trial

Michael Hudson, Paul Armstrong, William O'Neill, Amanda Stebbins, W Weaver, Petr Widimsky, Philip Aylward, Witold Ruzyllo, David Holmes Jr, Kenneth Mahaffey, Christopher Granger

    Research output: Contribution to journalArticlepeer-review

    23 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Mortality Implications of Primary Percutaneous Coronary Intervention Treatment Delays: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction Trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences